RYBREVANT® + chemotherapy work together to target and fight cancer

RYBREVANT® is a targeted antibody* that works against EGFR in 2 main ways:

RYBREVANT® blocks EGFR activityRYBREVANT® blocks EGFR activity

Helps stop the activity cancer cells use to grow and spread

RYBREVANT® combats EGFR cellsRYBREVANT® combats EGFR cells

Works with your body's immune system to help destroy the cancer

RYBREVANT® is not chemotherapy, but works with it

  • Chemotherapy is a key part of the treatment that stops cancer cells from dividing and growing
  • RYBREVANT® and chemotherapy are effective together because they destroy cancer cells in different ways

Chemotherapy = carboplatin + pemetrexed

*Antibodies are protective proteins that help detect harmful substances and diseases such as cancers. They are made naturally by your immune system and can also be man made. Man-made antibodies used to treat cancer have a specific target on a cancer cell that they aim to find, attach to, and attack. RYBREVANT® is a man-made antibody.

Side effects

There are side effects that you may experience during treatment with RYBREVANT®.

Doctor discussing possible side effects with RYBREVANT® patientDoctor discussing possible side effects with RYBREVANT® patient

Savings & Support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant® with meRybrevant® with me

EGFR = epidermal growth factor receptor; NSCLC = non–small cell lung cancer